William Valle insider trades: TriSalus Life Sciences (TLSI) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where William reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | TLSI | ↑ Buy | 30,487 | $4.10 | $125K | Direct | Feb 23, 2026 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TLSI insiders
Open-market trades in the last 12 months
About William Valle's insider trades
William Valle is a director at TriSalus Life Sciences (TLSI). Since Feb 23, 2026, William has reported 1 open-market purchase worth $125K and no sales on SEC Form 4. In the last 12 months: 1 buy ($125K).
Their filings also include grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TLSI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.